Folkvaljon Y - Search Results

1

Socioeconomic factors and penile cancer risk and mortality; a population-based study.

Torbrand C, Wigertz A, Drevin L, Folkvaljon Y, Lambe M, Håkansson U, Kirrander P. Torbrand C, et al. Among authors: folkvaljon y. BJU Int. 2017 Feb;119(2):254-260. doi: 10.1111/bju.13534. Epub 2016 Jul 4. BJU Int. 2017. PMID: 27373878

2

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.

Wulaningsih W, Garmo H, Ahlgren J, Holmberg L, Folkvaljon Y, Wigertz A, Van Hemelrijck M, Lambe M. Wulaningsih W, et al. Among authors: folkvaljon y. Breast Cancer Res Treat. 2018 Nov;172(1):167-177. doi: 10.1007/s10549-018-4890-z. Epub 2018 Jul 21. Breast Cancer Res Treat. 2018. PMID: 30030708 Free PMC article.

3

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck M, Folkvaljon Y, Adolfsson J, Akre O, Holmberg L, Garmo H, Stattin P. Van Hemelrijck M, et al. Among authors: folkvaljon y. BJU Int. 2016 Mar;117(3):507-14. doi: 10.1111/bju.13059. Epub 2015 May 15. BJU Int. 2016. PMID: 25604807 Free PMC article.

4

Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.

Loeb S, Folkvaljon Y, Lambe M, Robinson D, Garmo H, Ingvar C, Stattin P. Loeb S, et al. Among authors: folkvaljon y. JAMA. 2015 Jun 23-30;313(24):2449-55. doi: 10.1001/jama.2015.6604. JAMA. 2015. PMID: 26103029

5

Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study.

Thomsen FB, Folkvaljon Y, Garmo H, Robinson D, Loeb S, Ingvar C, Lambe M, Stattin P. Thomsen FB, et al. Among authors: folkvaljon y. Int J Cancer. 2016 May 1;138(9):2154-60. doi: 10.1002/ijc.29961. Epub 2016 Jan 18. Int J Cancer. 2016. PMID: 26662367

6

Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden.

Franck Lissbrant I, Ventimiglia E, Robinson D, Törnblom M, Hjälm-Eriksson M, Lambe M, Folkvaljon Y, Stattin P. Franck Lissbrant I, et al. Among authors: folkvaljon y. Scand J Urol. 2018 Apr;52(2):143-150. doi: 10.1080/21681805.2018.1426039. Epub 2018 Feb 1. Scand J Urol. 2018. PMID: 29385878 Free article.

7

Upper limit of cancer extent on biopsy defining very low-risk prostate cancer.

Bratt O, Folkvaljon Y, Loeb S, Klotz L, Egevad L, Stattin P. Bratt O, et al. Among authors: folkvaljon y. BJU Int. 2015 Aug;116(2):213-9. doi: 10.1111/bju.12874. Epub 2015 Mar 7. BJU Int. 2015. PMID: 25053197

8

Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.

Bratt O, Folkvaljon Y, Hjälm Eriksson M, Akre O, Carlsson S, Drevin L, Franck Lissbrant I, Makarov D, Loeb S, Stattin P. Bratt O, et al. Among authors: folkvaljon y. Eur Urol. 2015 Jul;68(1):53-8. doi: 10.1016/j.eururo.2014.12.026. Epub 2015 Mar 23. Eur Urol. 2015. PMID: 25813688 Free article.

9

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.

Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P. Loeb S, et al. Among authors: folkvaljon y. J Clin Oncol. 2017 May 1;35(13):1430-1436. doi: 10.1200/JCO.2016.69.5304. Epub 2017 Mar 13. J Clin Oncol. 2017. PMID: 28447913 Free PMC article.

10

Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.

Joneborg U, Folkvaljon Y, Papadogiannakis N, Lambe M, Marions L. Joneborg U, et al. Among authors: folkvaljon y. Acta Oncol. 2018 Aug;57(8):1094-1099. doi: 10.1080/0284186X.2018.1438653. Epub 2018 Feb 16. Acta Oncol. 2018. PMID: 29451409 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters